- External Validation of Histologic Chronicity Score + Kidney Failure Risk Equation to Predict Disease Progression in Biopsy Proven IgA Nephropathy in Filipino Patients in a Tertiary Institution in the Philippines
-
Marcelle Louise Aquino
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- Impact of Real-World Off-Label Dose of Apixaban on Long-Term Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation and Chronic Kidney Disease
-
Ye Na Kim
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- Optimizing CKD Management: Aligning with Guidelines and SGLT2 Inhibitor's Role
-
Merlin Thomas
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- Patient Response and Outcomes of Protocol Directed Management Therapy Among Filipino Patients With Iga Nephropathy Seen in the Outpatient Department of A Tertiary Hospital from 2021-2023
-
Hygeia Laurei Fernandez
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- Preventive Impact and Optimization of Statin Therapy in Patients With Chronic Kidney Disease Admitted to the Intensive Care Unit: A Deep Learning-Based Causal Inference Study
-
Min Woo Kang
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- Unlocking Renal Benefits: SGLT2 Inhibitors in CKD
-
So-Young Lee
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- Prognostic Implications of Dynamic Change in Glomerular C3 Deposition in Membranous Nephropathy
-
WON HEE CHO
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- Effect of Modifiable Risk Factors on End Stage Kidney Disease
-
NAMJU HEO
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- SGLT2i: A Comprehensive Approach to Cardio-Renal-Matabolic Disease Management
-
Young Youl Hyun
2025 ; 2025(1):
-
초록보기
PDF 원문보기
- Longer Follow-up of Povetacicept Shows Potential for Treatment of Primary Membranous Nephropathy (RUBY-3 Study)
-
Sung Gyun Kim
2025 ; 2025(1):
-
초록보기
PDF 원문보기